Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

NCT01427725 · clinicaltrials.gov ↗

COMPLETED

Status

579

Enrollment

INDUSTRY

Sponsor class

Conditions

Exocrine Pancreatic Insufficiency
Pancreatic Diseases
Digestive System Diseases

Interventions

DRUG: Lipacreon

Sponsor

Mylan Inc.